Radiation-induced lung injury.
The use of radiation therapy is limited by the occurrence of the potentially fatal clinical syndromes of radiation pneumonitis and fibrosis. Radiation pneumonitis usually becomes clinically apparent from 2 to 6 months after completion of radiation therapy. It is characterized by fever, cough, dyspnea, and alveolar infiltrates on chest roentgenogram and may be difficult to differentiate from infection or recurrent malignancy. The pathogenesis is uncertain, but appears to involve both direct lung tissue toxicity and an inflammatory response. The syndrome may resolve spontaneously or may progress to respiratory failure. Corticosteroids may be effective therapy if started early in the course of the disease. The time course for the development of radiation fibrosis is later than that for radiation pneumonitis. It is usually present by 1 year following irradiation, but may not become clinically apparent until 2 years after radiation therapy. It is characterized by the insidious onset of dyspnea on exertion. It most often is mild, but can progress to chronic respiratory failure. There is no known successful treatment for this condition.
Rosiello
R A
RA
Department of Internal Medicine, Yale University Medical Center, New Haven, Connecticut.
Merrill
W W
WW
D000818:Animals; D006801:Humans; D011658:Pulmonary Fibrosis / Q000209:etiology* / Q000473:pathology / Q000628:therapy; D011832:Radiation Injuries; D011833:Radiation Injuries, Experimental; D011878:Radiotherapy / Q000009:adverse effects; D013577:Syndrome; D013997:Time Factors